Where FDA breakthrough devices stand through 2025: growth, authorizations, leading specialties, AI trends, and qualification pathways explained.
The PRPS guidelines provide a uniform foundation across government regulators to reduce illness and outbreaks related to produce.
Psychedelic drug development can still benefit from the FDA Commissioner’s National Priority Review Voucher Pilot Program, though the CNPV designation was not given to Compass Pathways’ synthetic ...
WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored by President Donald Trump’s administration is causing alarm across the ...
Add Yahoo as a preferred source to see more of our stories on Google. Dr. Marty Makary, commissioner of the Food and Drug Administration, speaks in the Oval Office of the White House during an event ...
Sentante announced that its Sentante stroke system has been accepted into the FDA Total Product Life Cycle Advisory Program ...
April 22 (Reuters) - The U.S. Food and Drug Administration on Tuesday proposed speeding up medical device approvals for patients who have no other treatment options through a new program focused on ...
MacroGenics (MGNX) fell ~18% in the premarket on Tuesday after the cancer drug developer announced that the U.S. FDA has ...
Hosted on MSN
Legal questions swirl around FDA's new expedited drug program, including who should sign off
WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results